Moisoi Nicoleta: Difference between revisions
Nirschl Lisa (talk | contribs) No edit summary |
Tindle Lisa (talk | contribs) No edit summary |
||
(10 intermediate revisions by 6 users not shown) | |||
Line 4: | Line 4: | ||
|COST Mentor= Mentor | |COST Mentor= Mentor | ||
}} | }} | ||
: [[ | : [[Management_Committee_MitoEAGLE#WG_Leaders_and_Co-Leaders |WG4 Leader]] - [[Management Committee MitoEAGLE]] | ||
{{Person | {{Person | ||
Line 10: | Line 10: | ||
|firstname=Nicoleta | |firstname=Nicoleta | ||
|title=Dr. | |title=Dr. | ||
|institution=[[File:MoisoiN.jpg|right|150px|Nicoleta Moisoi]] | |institution=[[File:MoisoiN.jpg|right|150px|Nicoleta Moisoi]] Leicester School of Pharmacy, | ||
Faculty of Health Sciences, | |||
De Montfort University, UK | |||
De Montfort University | |||
|address=The Gateway | |address=The Gateway | ||
Line 27: | Line 23: | ||
|mailaddress=nicoleta.moisoi@dmu.ac.uk | |mailaddress=nicoleta.moisoi@dmu.ac.uk | ||
}} | }} | ||
__TOC__ | |||
== Bioenergetics Communications == | |||
::::* Nicoleta Moisoi is an Associate Editor and on the Board of Reviewers for the journal '''[[Bioenergetics Communications]]''' | |||
==Participated at== | ::::: '''Keywords:''' animal models, cell models, mitochondria-nucleus crosstalk, neurodegeneration, signaling | ||
::::* [[ | == Participated at == | ||
::::* [[FAT4BRAIN Workshop IOC151 Innsbruck AT]] | |||
::::* [[MiP2019/MitoEAGLE Belgrade RS|MitoEAGLE 2019 Belgrade RS]] | |||
::::*[[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]] | |||
::::* [[MiP2017/MitoEAGLE Hradec Kralove CZ|MitoEAGLE 2017 Hradec Kralove CZ]] | |||
::::* [[MitoEAGLE Barcelona 2017| MitoEAGLE 2017 Barcelona ES]] | |||
::::* [[MiPNet11.06 IOC36 | IOC36 Schroecken AT]] | |||
== | == MitoEAGLE == | ||
****: '''Benefits for COST and for the COST Action | ****: '''Benefits for COST and for the COST Action MitoEAGLE''' | ||
:::: My current research focuses on the role of mitochondria in neurodegenerative disease, particularly in Parkinson's disease. | :::: My current research focuses on the role of mitochondria in neurodegenerative disease, particularly in Parkinson's disease. | ||
{{Labelingperson | |||
|field of research=Basic | |||
}} | |||
Latest revision as of 11:31, 1 March 2023
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Moisoi Nicoleta
MitoPedia topics: MitoPedia topic::EAGLE
COST: Has COST::Member
COST WG4: Has COST WG4::WG4 COST Mentor: Has COST Mentor::Mentor
Name | Has lastname::Moisoi Has firstname::Nicoleta, Has title::Dr. |
---|---|
Institution | [[Has institution:: Leicester School of Pharmacy,
Faculty of Health Sciences, De Montfort University, UK]] |
Address | [[Has address::The Gateway
Hawthorn Building 1.03]], Has area code::LE1 9BH |
City | In city::Leicester |
State/Province | In state:: |
Country | In country::United Kingdom |
Has mailaddress::nicoleta.moisoi@dmu.ac.uk | |
Weblink | Weblink:: |
O2k-Network Lab | {{#ask:has member::Moisoi Nicoleta}} |
Bioenergetics Communications
- Nicoleta Moisoi is an Associate Editor and on the Board of Reviewers for the journal Bioenergetics Communications
- Keywords: animal models, cell models, mitochondria-nucleus crosstalk, neurodegeneration, signaling
Participated at
MitoEAGLE
- Benefits for COST and for the COST Action MitoEAGLE
- My current research focuses on the role of mitochondria in neurodegenerative disease, particularly in Parkinson's disease.
Labels:
Field of research: field of research::Basic
Publications
{{#ask:was written by::Moisoi Nicoleta|format=table|sort=was published in year|order=desc|default=Add references to your publications
| ?was published in year=Published
| ?has title=Reference
| limit=2000
}}
Abstracts
{{#ask:was written by::Moisoi Nicoleta|format=table|sort=was submitted in year|order=desc|default=Add abstract
| ?was submitted in year=Published
| ?has title=Reference
| limit=2000
}}